Premier Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-14,092
Closed -$399K 210
2020
Q4
$399K Buy
14,092
+3,301
+31% +$93.5K 0.08% 114
2020
Q3
$272K Buy
+10,791
New +$272K 0.07% 117
2019
Q3
Sell
-22,617
Closed -$293K 150
2019
Q2
$293K Buy
+22,617
New +$293K 0.07% 123